523 related articles for article (PubMed ID: 30871576)
21. Genetically engineered CAR NK cells display selective cytotoxicity against FLT3-positive B-ALL and inhibit in vivo leukemia growth.
Oelsner S; Waldmann A; Billmeier A; Röder J; Lindner A; Ullrich E; Marschalek R; Dotti G; Jung G; Große-Hovest L; Oberoi P; Bader P; Wels WS
Int J Cancer; 2019 Oct; 145(7):1935-1945. PubMed ID: 30860598
[TBL] [Abstract][Full Text] [Related]
22. Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T Activation.
Guo T; Ma D; Lu TK
ACS Synth Biol; 2022 Apr; 11(4):1440-1453. PubMed ID: 35316028
[TBL] [Abstract][Full Text] [Related]
23. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
24. Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.
De Oliveira SN; Ryan C; Giannoni F; Hardee CL; Tremcinska I; Katebian B; Wherley J; Sahaghian A; Tu A; Grogan T; Elashoff D; Cooper LJ; Hollis RP; Kohn DB
Hum Gene Ther; 2013 Oct; 24(10):824-39. PubMed ID: 23978226
[TBL] [Abstract][Full Text] [Related]
25. Engagement of an optimized lentiviral vector enhances the expression and cytotoxicity of CAR in human NK cells.
Guo C; Chen H; Yu J; Lu H; Xia Q; Li X; Guo X; Wang T; Zhi L; Niu Z; Zhu W
Mol Immunol; 2023 Mar; 155():91-99. PubMed ID: 36736195
[TBL] [Abstract][Full Text] [Related]
26. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.
Bodor J; Bodorova J; Bare C; Hodge DL; Young HA; Gress RE
Eur J Immunol; 2002 Jan; 32(1):203-12. PubMed ID: 11754361
[TBL] [Abstract][Full Text] [Related]
27. A TCR-based Chimeric Antigen Receptor.
Walseng E; Köksal H; Sektioglu IM; Fåne A; Skorstad G; Kvalheim G; Gaudernack G; Inderberg EM; Wälchli S
Sci Rep; 2017 Sep; 7(1):10713. PubMed ID: 28878363
[TBL] [Abstract][Full Text] [Related]
28. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
[TBL] [Abstract][Full Text] [Related]
29. Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.
Müller N; Michen S; Tietze S; Töpfer K; Schulte A; Lamszus K; Schmitz M; Schackert G; Pastan I; Temme A
J Immunother; 2015 Jun; 38(5):197-210. PubMed ID: 25962108
[TBL] [Abstract][Full Text] [Related]
30. Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells.
Wang X; Jasinski DL; Medina JL; Spencer DM; Foster AE; Bayle JH
Blood Adv; 2020 May; 4(9):1950-1964. PubMed ID: 32384544
[TBL] [Abstract][Full Text] [Related]
31. Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4.
Jamali A; Hadjati J; Madjd Z; Mirzaei HR; Thalheimer FB; Agarwal S; Bonig H; Ullrich E; Hartmann J
Front Immunol; 2020; 11():2028. PubMed ID: 32983147
[TBL] [Abstract][Full Text] [Related]
32. Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients.
Xiao L; Cen D; Gan H; Sun Y; Huang N; Xiong H; Jin Q; Su L; Liu X; Wang K; Yan G; Dong T; Wu S; Zhou P; Zhang J; Liang W; Ren J; Teng Y; Chen C; Xu XH
Mol Ther; 2019 Jun; 27(6):1114-1125. PubMed ID: 30962163
[TBL] [Abstract][Full Text] [Related]
33. Production of human CAR-NK cells with lentiviral vectors and functional assessment
Portillo AL; Hogg R; Ashkar AA
STAR Protoc; 2021 Dec; 2(4):100956. PubMed ID: 34825217
[TBL] [Abstract][Full Text] [Related]
34. Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors.
Mo F; Mamonkin M
Methods Mol Biol; 2020; 2086():119-130. PubMed ID: 31707671
[TBL] [Abstract][Full Text] [Related]
35. Bacteria-free minicircle DNA system to generate integration-free CAR-T cells.
Cheng C; Tang N; Li J; Cao S; Zhang T; Wei X; Wang H
J Med Genet; 2019 Jan; 56(1):10-17. PubMed ID: 30030293
[TBL] [Abstract][Full Text] [Related]
36. CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements.
Vazquez BN; Laguna T; Carabana J; Krangel MS; Lauzurica P
J Immunol; 2009 Nov; 183(10):6513-21. PubMed ID: 19841192
[TBL] [Abstract][Full Text] [Related]
37. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
Oelsner S; Friede ME; Zhang C; Wagner J; Badura S; Bader P; Ullrich E; Ottmann OG; Klingemann H; Tonn T; Wels WS
Cytotherapy; 2017 Feb; 19(2):235-249. PubMed ID: 27887866
[TBL] [Abstract][Full Text] [Related]
38. Inducible localized delivery of an anti-PD-1 scFv enhances anti-tumor activity of ROR1 CAR-T cells in TNBC.
Harrasser M; Gohil SH; Lau H; Della Peruta M; Muczynski V; Patel D; Miranda E; Grigoriadis K; Grigoriadis A; Granger D; Evans R; Nathwani AC
Breast Cancer Res; 2022 Jun; 24(1):39. PubMed ID: 35659040
[TBL] [Abstract][Full Text] [Related]
39. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
Bashiri Dezfouli A; Yazdi M; Benmebarek MR; Schwab M; Michaelides S; Miccichè A; Geerts D; Stangl S; Klapproth S; Wagner E; Kobold S; Multhoff G
Front Immunol; 2022; 13():883694. PubMed ID: 35720311
[TBL] [Abstract][Full Text] [Related]
40. Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer.
Cao B; Liu M; Wang L; Liang B; Feng Y; Chen X; Shi Y; Zhang J; Ye X; Tian Y; Zhi C; Li J; Lian H; Wu Q; Zhang Z
Biochem Biophys Res Commun; 2020 Mar; 524(1):96-102. PubMed ID: 31980173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
